Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study

A prospective randomized phase II trial was conducted to evaluate the time course effects of toremifene (TOR) and letrozole (LET), as adjuvant hormone therapy, on serum lipid profiles and bone metabolism in estrogen receptor (ER)-positive, postmenopausal breast cancer patients.Fifty-four postmenopau...

Descripción completa

Detalles Bibliográficos
Autores principales: Shien, Tadahiko, Doihara, Hiroyoshi, Sato, Nobuaki, Anan, Keisei, Komaki, Kansei, Miyauchi, Keisuke, Yanagita, Yasuhiro, Fujisawa, Tomomi, Mitsuyama, Shoshu, Kanbayashi, Chizuko, Kusama, Mikihiro, Kimura, Morihiko, Jinno, Hiromitsu, Sano, Muneaki, Ikeda, Tadashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778152/
https://www.ncbi.nlm.nih.gov/pubmed/29196963
http://dx.doi.org/10.1007/s00280-017-3491-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778152/
https://www.ncbi.nlm.nih.gov/pubmed/29196963
http://dx.doi.org/10.1007/s00280-017-3491-6

Ejemplares similares